Clinical Trials Logo

Clinical Trial Summary

The AMILOR study compares treatment of edema in nephrotic syndrome with Amiloride vs. Furosemide.


Clinical Trial Description

The monocenter randomized-controlled AMILOR trial investigates the efficacy of the ENaC blocker amiloride in reducing edema in nephrotic syndrome compared with standard therapy with the loop diuretic furosemide. Patients with acute nephrotic syndrome are randomized to receive amiloride (starting dose 5 mg) or furosemide (starting dose 40 mg) for 16 days. The target number of patients is n = 18 per arm. Exclusion criteria include GFR <30ml/min/1.73m², AKIN 1 and 2, hypotension, hyper-/ hypokalemia, and hyponatremia. Overhydration is quantified by bioimpedance spectroscopy. Depending on the course of overhydration, dose adjustments (day 2, 5, 8, 12) or addition of HCT (day 8) are performed during the course of the study. Primary endpoint is decrease in overhydration at day 8, secondary endpoints include decrease in overhydration at day 16, as well as body weight, edema volume, blood pressure, urine volume, natriuresis at day 8 and 16, and need for dose adjustments and co-medication with HCT. Plasma potassium, sodium, and creatinine concentrations are measured as safety parameters. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05079789
Study type Interventional
Source University Hospital Tuebingen
Contact
Status Terminated
Phase Phase 3
Start date June 8, 2020
Completion date November 20, 2022

See also
  Status Clinical Trial Phase
Completed NCT06003205 - Contributing Factors to Local Bioimpedance Spectroscopy N/A
Completed NCT02055872 - Furosemide and Albumin for Diuresis of Edema: A Pilot Randomized Controlled Trial Phase 3
Completed NCT01172522 - Topical Treatment of Under Eye Dark Circles and Swelling Phase 2
Completed NCT00602615 - Bioequivalency Study of Torsemide Tablets Under Fed Conditions N/A
Completed NCT00602303 - Bioequivalency Study of Torsemide Tablets Under Fasting Conditions N/A
Completed NCT00115726 - Trial Assessing the Effect of Preoperative Furosemide on Intraoperative Blood Pressure Phase 4
Completed NCT04595448 - Lymphatic Function in Patients With Secondary Tricuspid Valve Regurgitation
Recruiting NCT06014203 - Examination of Edema After Arthroscopic Shoulder Surgery
Completed NCT06010394 - Control of Edema in the Knee in Patients With Knee Osteoarthritis N/A
Recruiting NCT05310019 - Effect of Electroacupuncture in Patients Submitted Orthognathic Surgery and Mentoplasty N/A
Recruiting NCT03442166 - Effectiveness of Light-emitting Diode (LED) Photobiomodulation in the Extraction of Retained Lower Third Molars Phase 2
Withdrawn NCT03603990 - Effect of Vitrectomy on the Evolution of Refractory Diabetic Macular Edema N/A
Completed NCT06220903 - The Effect of Complex Decongestive Therapy in Patients With Lymphedema N/A
Recruiting NCT04927234 - Foot and Ankle Post-operative Oedema Management Using Geko™ N/A
Active, not recruiting NCT02876107 - Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer Phase 2
Recruiting NCT03704857 - Different Endodontic Treatment Techniques in Postoperative Symptoms, Apical Repair, Longevity of Rehabilitations, and Oral Health-related Quality of Life N/A
Recruiting NCT04606030 - LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge) N/A
Completed NCT00732719 - Compression Device Safety Study on Edema Phase 2
Not yet recruiting NCT05534308 - Effect of Intraoperative Taping on the Control of Edema Resulting From Stripping N/A
Completed NCT04205253 - Tongue Depressor-related Ischemia-Reperfusion Injury in Tongue